2024’s critical needle-free approvals for pediatric anaphylaxis, influenza
Needle-free treatments, such as Neffy and FluMist, offer promising alternatives for children and adults with needle phobia, ensuring access to critical care.
Food Insecurity and the Dangers of Infant Formula Dilution
Tiny Tim: What the diagnosis?
Can you guess what condition Tiny Tim had?
Demystifying Infant Formula
COVID-19 Roundtable: Prophylaxis for the immunocompromised
This week the panel weighs in on monoclonal antibodies in this patient population as well as important overall takeaways about COVID-19 therapies.
FDA approves concizumab-mtci prophylaxis for hemophilia A and B
The indication is for patients 12 years and older hemophilia A with factor VIII inhibitors or hemophilia B with factor IX inhibitors.
